RNAC Operating Cash Flow (Statement)
Cartesian Therapeutics Inc · Operating Cash Flow (Statement)
RNAC Operating Cash Flow (Statement)
Latest reported-$76.07Mperiod ending
RNAC TTM Cash from Operations (-$22.46M → -$76.07M)
TTM operating cash flow (statement)
High-resolution chart · PNG
RNAC operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -76,073,000 | |
| -72,968,000 | |
| -73,941,000 | |
| -63,231,000 | |
| -33,940,000 | |
| -30,865,000 | |
| -23,674,000 | |
| -39,958,000 | |
| -62,864,000 | |
| -58,313,000 | |
| -51,161,000 | |
| -39,724,000 | |
| -26,156,000 | |
| -28,532,000 | |
| -31,631,000 | |
| -51,242,000 | |
| -66,341,000 | |
| -60,113,000 | |
| -60,382,000 | |
| -36,172,000 | |
| 40,211,000 | |
| 34,446,000 | |
| 34,881,000 | |
| 29,255,000 | |
| -47,504,000 | |
| -42,893,000 | |
| -51,435,000 | |
| -51,307,000 | |
| -56,216,000 | |
| -65,992,000 | |
| -59,161,000 | |
| -59,085,000 | |
| -58,489,000 | |
| -50,130,000 | |
| -52,037,000 | |
| -37,809,000 | |
| -27,840,000 | |
| -24,833,000 | |
| -19,683,000 | |
| -28,879,000 | |
| -29,025,000 | |
| -27,731,000 | |
| -22,463,000 |